Vanadium Compounds: Biochemical and Therapeutic Applications edited by Ashok K. Srivastava, Jean-Louis Chiasson.

Saved in:

Bibliographic Details
Corporate Author:	SpringerLink (Online service)
Other Authors:	Srivastava, Ashok K. (Editor), Chiasson, Jean-Louis (Editor)
Format:	eBook
Language:	English
Published:	New York, NY : Springer US : Imprint: Springer, 1995.
Edition:	1st ed. 1995.
Series:	Developments in Molecular and Cellular Biochemistry ; 16 Springer eBook Collection.
Subjects:	Endocrinology . Diabetes. Medical biochemistry. Electronic resources (E-books)
Online Access:	Click to view e-book
Holy Cross Note:	Loaded electronically. Electronic access restricted to members of the Holy Cross Community.

Table of Contents:

I: Chemistry
The chemistry of peroxovanadium compounds relevant to insulin mimesis
Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents
Peroxo heteroligand vanadates(V): Synthesis, spectra-structure relationships, and stability toward decomposition
Chemically and photochemically initiated DNA cleavage by an insulin-mimetic bisperoxovanadium complex
II: Biochemical and physiological studies
Insulin-like actions of vanadate are mediated in an insulin-receptor-independent manner via non-receptor protein tyrosine kinases and protein phosphotyrosine phosphatases
Peroxovanadium compounds: Biological actions and mechanism of insulin-mimesis
Unique and selective mitogenic effects of vanadate on SV40-transformed cells
Vanadium salts stimulate mitogen-activated protein (MAP) kinases and ribosomal S6 kinases
Protective effect of vanadate on oxyradical-induced changes in isolated perfused heart
In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals
The relationship between insulin and vanadium metabolism in insulin target tissues
Modulation of insulin action by vanadate: Evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling
Reversal of defective G-proteins and adenylyl cyclase/cAMP signal transduction in diabetic rats by vanadyl sulphate therapy
Effects of vanadate on the expression of genes involved in fuel homeostasis in animal models of Type I and Type II diabetes
Decrease in protein tyrosine phosphatase activities in vanadate-treated obese Zucker (fa/fa) rat liver
Evidence for selective effects of vanadium on adipose cell metabolism involving actions on cAMP-dependent protein kinase
The enhancement by pervanadate of tyrosine phosphorylation on prostatic proteins occurs through the inhibition of membrane-associated tyrosine phosphatases
Contractile effects of vanadate on aorta rings from virgin and pregnant rats
In vivo modulation of N-myristoyltransferase activity by orthovanadate
Regulation and control of glucose overutilization in erythrocytes by vanadate
In vitro and in vivo antineoplastic effects of ortrovanadate
Membrane — vanadium interaction: A toxicokinetic evaluation
III: Potential use in therapy and toxicological studies
Increased potency of vanadium using organic ligands
In vivo effects of peroxovanadium compounds in BB rats
Long-term antidiabetic activity of vanadyl after treatment withdrawal: Restoration of insulin secretion?
Long-term correction of STZ-diabetic rats after short-term i.p. VOSO4 treatment: Persistence of insulin secreting capacities assessed by isolated pancreas studies
Antihypertensive effects of vanadium compounds in hyperinsulinemic, hypertensive rats
Vanadate induces normolipidemia and a reduction in the levels of hepatic iipogenic enzymes in obese Zucker rat
In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus
Toxicology of vanadium compounds in diabetic rats: The action of chelating agents on vanadium accumulation
Index to Volume 153.

Vanadium Compounds: Biochemical and Therapeutic Applications edited by Ashok K. Srivastava, Jean-Louis Chiasson.

Similar Items